Capital Flow Monitor · Sponsors · CIK 1851943
Alloy Therapeutics, Inc.
275 SECOND AVE, WALTHAM, MA, 02451 · 617-203-7111
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$40.0M
Sold
$30.0M
% sold
75.1%
Investors
11
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-04-15 | D ·current | 506(b) | $40.0M | $30.0M | 75.1% | 11 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Jason Coloma — Director, WALTHAM, MA
1 other raise
- Ollin Biosciences, Inc. $156.2M of $330.0M · 47.3%
-
Errik B. Anderson — Executive Officer / Director, WALTHAM, MA
2 other raises
- Human Biotech, Inc. $10.0M of $10.0M · 100.0%
- Cantai Therapeutics, Inc. $3.0M of $3.0M · 100.0%
- Logan Snyder — Director, WALTHAM, MA
- Ulrik Nielsen — Director, WALTHAM, MA
-
Jason Camm — Director, WALTHAM, MA
1 other raise
- Angiex, Inc. $22.0M of $28.4M · 77.4%
-
Alex Kolicich — Director, WALTHAM, MA
1 other raise
- Qualia Labs, Inc. $50.0M of $50.0M · 100.0%
- Piotr Bobrowicz — Executive Officer / Director, WALTHAM, MA
-
Anthony Sun — Director, WALTHAM, MA
1 other raise
- Senza Research, Inc. $2.2M of $16.0M · 13.4%
-
Alaa Halawa — Director, WALTHAM, MA
3 other raises
- Ollin Biosciences, Inc. $156.2M of $330.0M · 47.3%
- MC Healthcare Ventures II LP $0 of —
- InnovAccer Inc. $2.1M of —
-
Christian Kanady — Director, WALTHAM, MA
1 other raise
- Echo ATX I, LLC $1.5M of —
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.